Related scientific articles (all)

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Authors : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Year : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pages : 448-54

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Authors : Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, + collaborators (among others :, Dal Lago L, de Azambuja E, Dabakuyo-Yonli TS
Year : 2015
Journal : Ann Oncol
Volume : 26(5)
Pages : 873-879.

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up.

Authors : Dallaudière B, Kerger J, Malghem J, Galant C, Lecouvet FE
Year : 2015
Journal : Acta Radiol Open
Volume : 4(2)
Pages : 2047981614552217

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

Authors : Fumagalli D, Gacquer D, Rothé F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, Larsimont D, Polyak K, Willard-Gallo K, Desmedt C, Piccart-Gebhart M, Abramowicz M, Campbell PJ, Sotiriou C, Detours V
Year : 2015
Journal : Cell Rep
Volume : 13
Pages : 277-89

Evolving paradigms in multifocal breast cancer.

Authors : Salgado R, Aftimos P, Sotiriou C, Desmedt C
Year : 2015
Journal : Semin. Cancer Biol.
Volume : 31C
Pages : 111-118

Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.

Authors : Twelves C, Cortes J, Vahdat L, Olivo M, He Y, Kaufman PA, Awada A
Year : 2015
Journal : Breast Cancer Res. Treat.
Volume : 149(1)
Pages : 313

Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma.

Authors : Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelholm JL, Gomez Galdon M, Deleporte A, Hendlisz A, Vanderlinden B, Flamen P, Donckier V
Year : 2015
Journal : World J Gastroenterol
Volume : 21
Pages : 9666-70

Adjuvant systemic therapy in breast cancer: quo vadis?

Authors : Sonnenblick A, Piccart-Gebhart M
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1629-34

Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.

Authors : Nuciforo PG, Aura C, Holmes E, Prudkin L, Jimenez J, Martinez P, Ameels H, de la Peña L, Ellis C, Eidtmann H, Piccart-Gebhart M, Scaltriti M, Baselga J
Year : 2015
Journal : Ann Oncol
Volume : 26
Pages : 1494-500

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Authors : Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, Kaufman B, Paluch-Shimon S, Gewefel H, Gallerani E, Abulkhair O, Pistilli B, Warner E, Saloustros E, Perey L, Zaman K, Rabaglio M, Gelber S, Gelber Rd, Godhirsch A, Korde L, Azim HA, Partridge AH
Year : 2015
Journal : Breast
Volume : 24(3)
Pages : 201-7

Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Authors : de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M
Year : 2015
Journal : Eur J Cancer
Volume : 51
Pages : 2517-24

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.

Authors : Azim HA, Vingiani A, Peccatori F, Viale G, Loi S, Pruneri G
Year : 2015
Journal : Breast
Volume : 24(3)
Pages : 290-3

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.

Authors : Draganova D, Kerger J, Caspers L, Willermain F
Year : 2015
Journal : J Ophthalmic Inflamm Infect
Volume : 5
Pages : 17

High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.

Authors : Scaltriti M, Nuciforo P, Bradbury I, Sperinde J, Agbor-Tarh D, Campbell C, Chenna A, Winslow J, Serra V, Parra JL, Prudkin L, Jimenez J, Aura C, Harbeck N, Pusztai L, Ellis C, Eidtmann H, Arribas J, Cortes J, de Azambuja E, Piccart-Gebhart M, Baselga J
Year : 2015
Journal : Clin Cancer Res
Volume : 21(3)
Pages : 569-76

Vulvar metastasis from bladder cancer.

Authors : Aoun F, El Rassy E, Kourie HR, Hawaux E, Van Velthoven R
Year : 2015
Journal : Case Rep Obstet Gynecol
Volume : 2015
Pages : 324634

Evaluating the pharmacokinetics and pharmacodynamics of everolimus for treating breast cancer.

Authors : Gombos A, Barthélémy P, Awada A
Year : 2015
Journal : Expert Opin Drug Metab Toxicol
Volume : 11(5)
Pages : 823-34.

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Authors : Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L
Year : 2015
Journal : Ann Oncol
Volume : 26
Pages : 2408-19

Has the time come for genomic tests to guide the use of adjuvant chemotherapy in node-positive breast cancer?

Authors : Azim HA
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1521-3

New generations of targeted therapies fighting the resistance in solid tumors.

Authors : Barthélémy P, Aftimos P, Awada A
Year : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pages : 243-9

What can be learned from our pediatric colleagues?

Authors : Klastersky J
Year : 2015
Journal : Curr Opin Oncol
Volume : 27
Pages : 283-4